A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers

NCT00000808 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

NIH

Sponsor class

Conditions

HIV Infections
Pregnancy

Interventions

DRUG: Nevirapine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)